SYK

SELL

Stryker Corporation

Healthcare · Rank #141 · Analyzed Apr 20, 2026

$343.32

Current Price

$202.87

Intrinsic Value

-8.8%

Upside/Downside

4/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score4/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 8.8%

Fair Value Range

Low$46.83

Base (IV)$202.87

High$313.02

Entry Points

Conservative$46.83

Moderate$124.85

Aggressive$202.87

Quality & Moat Breakdown

Return on Equity15.1% → 1.0/1.0

Debt LevelD/E 73 → 0/1.0

Revenue QualityGrowth 11.2%, margin Δ+0.2% +recovery → 1.0/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins12.9% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.